Imiquimod 5% cream for the treatment of periocular Basal cell carcinoma.
Carneiro
Rachel Camargo
RC
Department of Ophthalmology and Otorhinolaryngology, University of São Paulo School of Medicine, São Paulo, Brazil. rccarneiro@msn.com
de Macedo
Erick Marcet Santiago
EM
Matayoshi
Suzana
S
D000368:Aged; D000634:Aminoquinolines / Q000008:administration & dosage* / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology; D005142:Eyelid Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000077271:Imiquimod; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010865:Pilot Projects; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D009824:Ointments; D000077271:Imiquimod